Effects of Cl2MDP-encapsulating liposomes in a murine model of Pseudomonas aeruginosa-induced sepsis

Journal of Liposome Research

Volumn 12, Issue 3, 2002, Pages 239-257

  Fujimoto, Junichi ^a   Wiener Kronish, Jeanine P ^a   Hashimoto, Satoru ^b   Sawa, Teiji ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

Bacterial infection; Clodronic acid; Macrophages

Indexed keywords

CLODRONIC ACID; CYTOKINE; INTERLEUKIN 10; LIPOSOME; MACROPHAGE INFLAMMATORY PROTEIN 2; TUMOR NECROSIS FACTOR ALPHA; CHEMOKINE; MIP 2 PROTEIN, MOUSE; MIP-2 PROTEIN, MOUSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTEREMIA; BACTERIAL PNEUMONIA; CONTROLLED STUDY; CRITICAL ILLNESS; ENCAPSULATION; LUNG INJURY; LUNG LAVAGE; MACROPHAGE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; SEPSIS; SEPTIC SHOCK; SURVIVAL; ANIMAL; BAGG ALBINO MOUSE; BLOOD; CHEMISTRY; COMPARATIVE STUDY; DRUG EFFECT; GERMFREE ANIMAL; GRAM NEGATIVE INFECTION; LUNG ALVEOLUS MACROPHAGE; MICROBIOLOGY;

ANIMALS; BRONCHOALVEOLAR LAVAGE FLUID; CHEMOKINES; CLODRONIC ACID; INTERLEUKIN-10; LIPOSOMES; MACROPHAGES; MACROPHAGES, ALVEOLAR; MALE; MICE; MICE, INBRED BALB C; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; SHOCK, SEPTIC; SPECIFIC PATHOGEN-FREE ORGANISMS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0036027197     PISSN: 08982104     EISSN: None     Source Type: Journal    
DOI: 10.1081/LPR-120014760     Document Type: Article

References (33)

1. Marsh, C.B.; Wewers, M.D. The pathogenesis of sepsis. Factors that modulate the response to gram-negative bacterial infection. In The Sepsis Syndrome. Clin. Chest Med. 1996, 17, 183-197.
2. van der Poll, T.; Deventer, S.J.H. Cytokines and anticytokines in the pathogenesis of sepsis. Infect. Dis. Clin. N. Am. 1999, 13, 413-426.
3. Green, S.J.; Turpin, J.A.; Nacy, C.A. Cytotoxic effector activities of macrophages. In Clinical Immunology: Principles and Practice; Rich, R.R., Fleisher, T.A., Schwartz, B.D., Shearer, W.T., Strober W., Eds.; Mosby-Year Book, Inc.: St. Louis, 1996; 290-298.
4. Brewer, S.C.; Wunderink, R.G.; Jones, C.B.; Leeper, K.V. Jr. Ventilator-sssociated pneumonia due to Pseudomonas aeruginosa. Chest 1996, 109, 1019-1029.
5. Craven, D.E.; Steger, K. Nosocomial pneumonia in mechanically ventilated adult patients: Epidemiology and prevention in 1996. Semin. Respir. Infect. 1996, 11, 32-53.
6. Wunderink, R.G. Ventilator-associated pneumonia. Failure to respond to antibiotics therapy. Clin. Chest Med. 1995, 16, 173-193.
7. Fagon, J.Y.; Chastre, J.; Hance, A.J.; Montravers, P.; Novara, A.; Gilbert, C. Nosocomial pneumonia in ventilated patients: A cohort study evaluating attributable mortality and hospital stay. Am. J. Med. 1993, 94, 281-288.
8. Taylor, G.D.; Buchanan-Chell, M.; Kirkland, T.; McKenzie, M.; Wiens, R. Bacteremic nosocomial pneumonia. A 7-year experience in one institution. Chest 1994, 108, 786-788.
9. Kudoh, I.; Wiener-Kronish, J.P.; Hashimoto, S.; Pittet, J.-F.; Frank, D. Exoproduct secretions of Pseudomonas aeruginosa strains influence severity of alveolar epithelial injury. Am. J. Physiol. 1994, 267, L551-L556.
10. Kurahashi, K.; Kajikawa, O.; Sawa, T.; Ohara, M.; Gropper, M.A.; Frank, D.W.; Martin, T.R.; Wiener-Kronish, J.P. Pathogenesis of septic shock in Pseudomonas aeruginosa pneumonia. J. Clin. Invest. 1999, 104, 743-750.
11. Sawa, T.; Yahr, T.L.; Ohara, M.; Kurahashi, K.; Gropper, M.A.; Wiener-Kronish, J.P.; Frank, D.W. Active and passive immunization with the Pseudomonas V antigen protects against type iii intoxication and lung injury. Nat. Med. 1999, 5, 392-398.
12. 2 in sepsis associated with Pseudomonas aeruginosa. J. Immunol. 2001, 167, 5880-5886.
13. Galan, J.E.; Collmer, A. Type III secretion machines: Bacterial devices for protein delivery into host cells. Science 1999, 284, 1322-1328.
14. Hueck, C.J. Type III Protein secretion systems in bacterial pathogens of animals and plants. Microbiol. Mol. Biol. Rev. 1998, 62, 379-433.
15. Finck-Barbancon, V.; Goranson, J.; Zhu, L.; Sawa, T.; Wiener-Kronish, J.P.; Fleiszig, S.M.; Wu, C.; Mende-Mueller, L.; Frank, D.W. ExoU expression by Pseudomonas aeruginosa correlates with acute cytotoxicity and epithelial injury. Mol. Microbiol. 1997, 25, 547-557.
16. Sawa, T.; Ohara, M.; Kurahashi, K.; Twining, S.S.; Frank, D.W.; Doroques, B.D.; Long, T.; Gropper, M.A.; Wiener-Kronish, J.P. In vitro cellular toxicity predicts Pseudomonas aeruginosa virulence in lung infections. Infect. Immun. 1998, 66, 3242-3249.
17. Yahr, T.L.; Goranson, J.; Frank, D.W. Exoenzyme S of Pseudomonas aeruginosa is secreted by a type III pathway. Mol. Microbiol. 1996, 22, 991-1003.
18. Yahr, T.L.; Mende-Mueller, L.M.; Friese, M.B.; Frank, D.W. Identification of type III secreted products of the Pseudomonas aeruginosa exoenzyme S regulon. J. Bacteriol. 1997, 179, 7165-7168.
19. Roy-Burman, A.; Savel, R.; Racine, S.; Swanson, B.L.; Ravadigar, N.S.; Fujimoto, J.; Sawa, T.; Frank, D.W.; Wiener-Kronish, J.P. Type-III protein secretion is associated with death in lower respiratory and systemic Pseudomonas aeruginosa infections. J. Infect. Dis. 2001, 183, 1767-1774.
20. Fleiszig, S.M.; Wiener-Kronish, J.P.; Miyazaki, H.; Vallas, V.; Mostov, K.E.; Kanada, D.; Sawa, T.; Yen, T.S.; Frank, D.W. Pseudomonas aeruginosa-mediated cytotoxicity and invasion correlate with distinct genotypes at the loci encoding exoenzyme S. Infect. Immun. 1997, 65, 579-586.
21. Sawa, T.; Corry, D.B.; Gropper, M.A.; Ohara, M.; Kurahashi, K.; Wiener-Kronish, J.P. IL-10 improves lung injury and survival in Pseudomonas aeruginosa pneumonia. J. Immunol. 1997, 159, 2858-2566.
22. van Rooijen, N. The liposome-mediated macrophage 'suicide' technique. J. Immunol. Methods 1989, 124, 1-6.
23. van Rooijen, N.; Sanders, A. Elimination, blocking, and activation of macrophages: Three of a kind? J. Leukocyte Biol. 1997, 62, 702-709.
24. van Rooijen, N.; Bakker, J.; Sanders, A. Transient suppression of macrophage functions by liposome-encapsulated drugs. TIBTECH 1997, 15, 178-185.
25. Hashimoto, S.; Pittet, J.-F.; Hong, K.; Folkesson, H.; Bagby, G.; Kobzik, L.; Frevert, C.; Watanabe, K.; Trurujuji, S.; Wiener-Kronish, J.P. Depletion of alveolar macrophages decreases neutrophil chemotaxis to Pseudomonas airspace infections. Am. J. Physiol. 1996, 270, L819-L824.
26. Kooguchi, K.; Hashimoto, S.; Kobayashi, A.; Kitamura, Y.; Kudoh, I.; Wiener-Kronish, J.P.; Sawa, T. Role of alveolar macrophages in initiation and regulation of inflammation in Pseudomonas aeruginosa pneumonia. Infect. Immun. 1998, 66, 3164-3169.
27. Espevik, T.; Nissen-Meyer, J. A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes. J. Immunol. Method. 1986, 95, 99-105.
28. Salkowski, C.A.; Neta, R.; Wynn, T.A.; Strassmann, G.; van Rooijen, N.; Vogel, S.N. Effect of liposome-mediated macrophage depletion on lps-induced cytokine gene expression and radioprotection. J. Immunol. 1995, 155, 3168-3179.
29. Samson, J.M.; Annema, A.; Groeneveld, P.H.P.; van Rooijen, N.; Langermans, J.A.M.; van Furth, R. Elimination of resident macrophages from the livers and spleens of immune mice impairs acquired resistance against a secondary Listeria monocytogenes infection. Infect. Immun. 1997, 65, 986-993.
30. Kuiper, J.A.; Brouwer, A.; Knock, D.L.; van Berkel, T.J.C. Kupffer and sinusoidal endothelial cells. In The Liver: Biology and Pathobiology; Arias, M., Boyer, J.L., Fausto, N., Jakoby, W.B., Schachter, D.A., Shafritz, D.A., Eds.; Raven Press: New York, 1994; 791-818.
31. Walley, K.R.; Lukacs, N.W.; Standiford, T.J.; Strieter, R.M.; Kunkel, S.L. Balance of inflammatory cytokines related to severity and mortality of murine sepsis. Infect. Immun. 1996, 64, 4733-4738.
32. Aramaki, Y.; Matsuno, R.; Nitta, F.; Arima, H.; Tsuchiya, S. Negatively charged liposomes inhibit tyrosine phosphorylation of 41-kDa protein in murine macrophages stimulated with LPS. Biochem. Biophys. Res. Comm. 1997, 231, 827-830.
33. Fadok, V.A.; Bratton, D.L.; Rose, D.M.; Pearson, A.; Ezekewitz, R.A.; Henson, P.M. A Receptor for phosphatidylserine-specific clearance of apoptotic cells. Nature 2000, 405, 85-90.